prospectivaconsultoria.com.br

  • Increase font size
  • Default font size
  • Decrease font size
PortuguêsEnglish
Home Clipping Pharmaceutical Industry
Pharmaceutical Industry

J&J regionalized command in Brazil and focuses on retail and SME

Monday, 12 July 2010 10:10
E-mail Print PDF

Johnson & Johnson Brazil (J&J) adopts a model of regionalization with autonomy of the sales teams in its division of consumer goods, which includes OTC. The area of OTC will focus the company's new strategy, including agressive sales models.

See more: Valor Econômico  

 

 MSD is restructuring and will deactivate one of its plants in Brazil

Friday, 09 July 2010 09:39
E-mail Print PDF

The Merck Sharp & Dohme (MSD, as it is known in Brazil) in its process of operational restructuring with the activities of Schering-Plough, will deactivate one of its plants in Brazil, while investing in the expansion of other plant to turn it in export platform to Latin America. The American Pharmaceutical company has 3 plants of drugs in Brazil. 

See more: Valor Econômico 

 

Mature drugs are "new" focus of laboratories

Friday, 02 July 2010 08:52
E-mail Print PDF

Traditional pharmaceutical companies, focused on research, start to invest more in medicines considered mature, ie, those which lose the patents but are good sales. Pfizer, Sanofi-Aventis and Merck (MSD) are investing in promoting this type of portfolio in Brazil.

See more Valor Econômico

 

With acquisition and partnerships, Aspen seeks to grow in Brazil

Wednesday, 30 June 2010 08:54
E-mail Print PDF

The pharmaceutical company Aspen, from South Africa, intends to expand its operations in Brazil through acquisitions and partnerships. The drugmaker, which acquired Cellofarma in the Brazilian market in 2008, acts in generic, OTC and licensing.

See more: Valor Econômico
 
More Articles...


Page 5 of 58